Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 11 2019
13 11 2019
Historique:
received:
13
05
2019
accepted:
31
10
2019
entrez:
15
11
2019
pubmed:
15
11
2019
medline:
27
10
2020
Statut:
epublish
Résumé
The pathogenesis of synucleinopathies, common neuropathological lesions normally associated with some human neurodegenerative disorders such as Parkinson's disease, dementia with Lewy bodies and multiple system atrophy, remains poorly understood. In animals, ingestion of the tryptamine-alkaloid-rich phalaris pastures plants causes a disorder called Phalaris staggers, a neurological syndrome reported in kangaroos. The aim of the study was to characterise the clinical and neuropathological changes associated with spontaneous cases of Phalaris staggers in kangaroos. Gross, histological, ultrastructural and Immunohistochemical studies were performed to demonstrate neuronal accumulation of neuromelanin and aggregated α-synuclein. ELISA and mass spectrometry were used to detect serum-borne α-synuclein and tryptamine alkaloids respectively. We report that neurons in the central and enteric nervous systems of affected kangaroos display extensive accumulation of neuromelanin in the perikaryon without affecting neuronal morphology. Ultrastructural studies confirmed the typical structure of neuromelanin. While we demonstrated strong staining of α-synuclein, restricted to neurons, intracytoplasmic Lewy bodies inclusions were not observed. α-synuclein aggregates levels were shown to be lower in sera of the affected kangaroos compared to unaffected herd mate kangaroos. Finally, mass spectrometry failed to detect the alkaloid toxins in the sera derived from the affected kangaroos. Our preliminary findings warrant further investigation of Phalaris staggers in kangaroos, potentially a valuable large animal model for environmentally-acquired toxic synucleinopathy.
Identifiants
pubmed: 31723225
doi: 10.1038/s41598-019-53396-8
pii: 10.1038/s41598-019-53396-8
pmc: PMC6853926
doi:
Substances chimiques
Alkaloids
0
Melanins
0
Plant Extracts
0
Protein Aggregates
0
Tryptamines
0
alpha-Synuclein
0
neuromelanin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
16546Références
Brain. 2005 Nov;128(Pt 11):2654-64
pubmed: 16000336
PLoS One. 2015 Apr 07;10(4):e0123162
pubmed: 25849645
Aust Vet J. 1946 Jun;22(3):91-4
pubmed: 21002201
Acta Neuropathol. 2011 Aug;122(2):187-204
pubmed: 21720849
Biochem Biophys Res Commun. 1984 Apr 30;120(2):574-8
pubmed: 6428396
J Neural Transm (Vienna). 2003 May;110(5):517-36
pubmed: 12721813
Lancet. 1983 Dec 24-31;2(8365-66):1457-9
pubmed: 6140548
Aust Vet J. 1990 Jul;67(7):248-51
pubmed: 2393371
Aust Vet J. 2011 Jul;89(7):243-6
pubmed: 21696371
Physiol Rev. 2004 Oct;84(4):1155-228
pubmed: 15383650
Curr Drug Metab. 2010 Oct;11(8):659-66
pubmed: 20942780
Neurosci Lett. 2000 Oct 6;292(2):128-30
pubmed: 10998565
Aust Vet J. 1948 Jan;24(1):12
pubmed: 18913889
J Am Vet Med Assoc. 1989 Aug 1;195(3):345-6
pubmed: 2768059
Neurosci Lett. 1985 Apr 9;55(2):179-84
pubmed: 2582318
Cancer Res. 1984 Mar;44(3):1128-34
pubmed: 6318981
Aust Vet J. 1987 Jan;64(1):31-2
pubmed: 3593138
J Am Vet Med Assoc. 1988 Mar 1;192(5):667-9
pubmed: 3372321
J Ethnopharmacol. 2008 Oct 28;119(3):549-58
pubmed: 18706990
Exp Dermatol. 2016 Oct;25(10):763-4
pubmed: 27248061
Neuroscience. 2003;118(4):985-1002
pubmed: 12732244
Acta Neuropathol. 2018 Jan;135(1):1-12
pubmed: 29039141
Neurology. 2000 May 23;54(10):1916-21
pubmed: 10822429
Am J Pathol. 1999 Oct;155(4):1173-81
pubmed: 10514400
J Am Vet Med Assoc. 1989 Sep 15;195(6):768-71
pubmed: 2793545
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13450-5
pubmed: 10557341
Aust Vet J. 1990 Oct;67(10):356-8
pubmed: 2288538
Science. 2000 Feb 18;287(5456):1265-9
pubmed: 10678833
Nature. 1988 Jul 28;334(6180):345-8
pubmed: 2899295
Proc Natl Acad Sci U S A. 1983 Jul;80(14):4546-50
pubmed: 6192438
Aust Vet J. 1966 Aug;42(8):279-86
pubmed: 6007941
Aust Vet J. 2014 Dec;92(12):504-8
pubmed: 25424766
Aust Vet J. 1999 Jun;77(6):401-2
pubmed: 10812410
J Pharmacol Exp Ther. 2003 Jul;306(1):73-83
pubmed: 12660312
Int J Neuropharmacol. 1967 May;6(3):223-8
pubmed: 5231771
J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):608-10
pubmed: 20522869
Vet Hum Toxicol. 1991 Oct;33(5):465-7
pubmed: 1746139
Acta Neuropathol. 1998 Nov;96(5):439-44
pubmed: 9829806
Aust Vet J. 2006 Dec;84(12):426-7
pubmed: 17156323
Neurosci Lett. 1999 Apr 9;265(1):67-9
pubmed: 10327208
J Virol. 2001 Oct;75(19):9320-7
pubmed: 11533195
Biomed Chromatogr. 2013 Dec;27(12):1690-700
pubmed: 23881860
Science. 1983 Feb 25;219(4587):979-80
pubmed: 6823561
Brain Res. 1984 Feb 6;292(2):390-4
pubmed: 6607092
Adv Neurol. 1987;45:179-82
pubmed: 3493625
PLoS One. 2010 Sep 14;5(9):e12728
pubmed: 20856865
Psychiatry Res. 1979 Dec;1(3):249-54
pubmed: 298352
Brain Pathol. 2016 May;26(3):410-8
pubmed: 26940058
FEBS Lett. 1994 May 23;345(1):27-32
pubmed: 8194594
Aust Vet J. 1999 Aug;77(8):537-8
pubmed: 10494401
Cancer Metastasis Rev. 1988 Jun;7(2):95-118
pubmed: 3293837
Exp Dermatol. 2016 Jul;25(7):501-4
pubmed: 26998907
J Neuropathol Exp Neurol. 1998 Apr;57(4):334-7
pubmed: 9600226
J Neural Transm (Vienna). 2006 Jun;113(6):741-9
pubmed: 16755378
J Vet Diagn Invest. 2010 Sep;22(5):802-5
pubmed: 20807948
Can J Neurol Sci. 1984 Feb;11(1):24-8
pubmed: 6704790
Neuroscience. 1999;91(2):651-9
pubmed: 10366022
Aust Vet J. 2005 Mar;83(3):168-71
pubmed: 15825630